Your dormant patient list is the cheapest revenue in your practice, and the reason it is not producing is almost never that the patients left. It is that the reactivation message is sent as a discount blast to everyone at once, instead of a clinically timed note to each patient at the point their last result wore off.
That is the whole argument. A patient who paid full price for tox five months ago does not need twenty percent off. They need someone to notice that their movement is back and offer them a slot. Those are two completely different businesses, and only one of them protects your average ticket.
Your quietest list is your cheapest revenue
Every practice we audit has the same hidden asset sitting in the practice management system: hundreds, often thousands, of people who already chose you, already paid, already consented, already know where to park. The acquisition cost on them was paid years ago.
Yet the budget goes almost entirely to strangers. Paid campaigns, new creative, new landing pages, all pointed at people who have never heard of the practice, while the list of people who already trusted you with their face gets one "we miss you" email in December.
The reason is not laziness. It is that reactivation is boring to build and easy to do badly, and most practices have been burned by a blast that generated a flurry of discount bookings and a worse month than the one before.
Sort by when the result wore off, not by how long ago they were in the list
This is the single change that separates reactivation that works from reactivation that annoys.
Most guides on this subject tell you to segment by list age: ninety days, one hundred eighty days, one year. That is retail logic applied to a patient file. It treats a tox patient and a filler patient at month five as the same person, when clinically they are nowhere near each other.
Use the treatment, not the calendar.
Neuromodulators. Published trial data gives you a precise anchor. In a pooled Phase III meta-analysis of day-30 responders, the median duration of effect for onabotulinumtoxinA was 120 days on the Facial Wrinkle Scale at maximum contraction and 131 days at rest. A 2022 Aesthetic Surgery Journal dose study states as background that onabotulinumtoxinA 20U reduces glabellar line severity at maximum frown for approximately three to four months. So the window is not a guess. A patient at month five is past peak and living with returning movement. That is your reason to reach out, and it is a clinical observation, not a promotion.
The guardrail matters just as much. Current dosing guidance recommends a minimum treatment interval of twelve weeks. Do not build an eight week reminder. You will invite a visit your injector declines, and you will look like you are selling rather than treating. Note also that duration varies by product and patient: abobotulinumtoxinA efficacy in glabellar lines at the recommended dose of 50U has extended to four to five months in randomized, double blind, placebo controlled studies, and up to six months for a small number of patients in an open label repeated cycle study. That variance is the argument for per patient timing rather than one date for the whole list.
Fillers. Duration differs sharply by product and by injection site, which is exactly why a blanket "filler patients at twelve months" rule misfires. Build your intervals off the approved labeling for the specific products your injectors actually use, and off what your own chart notes say about how long that patient held.
Laser and energy devices. These are protocol treatments, not calendar treatments. The reminder should fire on the series interval in the manufacturer instructions for use and in your clinical protocol, not on a quarterly marketing schedule. A patient who completed three of six sessions is not a lapsed patient. They are an unfinished course, and that is a different, easier conversation.
When you set it up this way, your "campaign" stops being a campaign. It becomes a set of standing triggers in your email marketing automation and your SMS reactivation system, firing one patient at a time, every week, forever.
Why the discount blast costs more than the bookings it buys
Two things go wrong when you lead with a percentage off.
The first is simple margin arithmetic. These are cash pay tickets. A twenty percent discount does not come out of an insurance reimbursement or a vendor rebate. It comes straight out of your margin, on the one line item in the practice with no cost offset.
The second is worse and slower. The patients most likely to respond to a discount are the ones who were already going to rebook. You are not buying a booking. You are buying a markdown on revenue you had coming anyway. And you are teaching your most loyal, least price sensitive patients a lesson they do not forget: wait, and Prime's offer will come. Run that quarterly for two years and you have trained your best list to hold out for the sale, and you have made full price feel like the penalty for booking early.
There is a place for an offer. It is narrow: a specific patient, a specific reason, usually tied to finishing a series or trying a treatment adjacent to one they already love. Not the whole file, not every quarter, not on the front of the message.
What the message actually says
Strip out the promo code and you are left with the thing that works: a personal, clinically specific reason to come back now.
The structure we use:
- Name the treatment and the date. "You were last in with Dr. Reyes for tox on March 4."
- Name what is happening now. Movement returning, the series paused at session three, the maintenance point in their plan.
- Make the ask small and specific. One slot, one week, one question. Not "book now," but "Thursday or the following Tuesday?"
- Leave the door open on why they stopped. One line that invites the truth. Patients go quiet because of a result they were not happy with, because their injector left, because of price, because a competitor opened down the road, or because life happened. A reactivation program that never asks is just noise, and you forfeit the one piece of information worth more than the booking.
Write it the way your front desk would say it out loud. If it reads like a newsletter, it will be treated like one.
Text or email, and who gets which
Keep it simple. Email carries the longer clinical explanation, before and afters where appropriate, and anything educational. SMS carries the short, time specific nudge to an individual patient who has an obvious open window.
Patient lists are not retail lists, and the rules that govern them are not marketing preference. SMS consent, opt out handling and quiet hours are governed by federal rules and by state level requirements that differ, and communications to patients about treatment and marketing fall under health privacy rules. Who decides varies: the FCC and state regulators on messaging, your state medical board on practice specific communication, and your own counsel on how health information is handled in a marketing send. Before any reactivation program goes live, have the consent language and the send list reviewed by someone qualified to review it. We build reactivation on a HIPAA aware approach throughout, and we still expect practices to run it past their own counsel.
The front desk closes it, marketing opens the door
This is where most reactivation dies. The message goes out, the replies come in, and nobody owns them.
A reactivation reply is a warm patient with their hand up. It needs a human response within the hour, with a named slot attached. Assign it: one person, one inbox, one phone line, with a standing block of appointment times held back for reactivated patients so the answer is never "we are full until June."
If your front desk cannot cover evenings and weekends, that is exactly where an AI receptionist earns its place, answering the reply, qualifying it and putting the appointment on the book while the patient is still interested.
One more thing to fix before you send. A dormant patient who is ready again often re-searches rather than scrolling back for a text from last year. If your practice is not showing up when an AI assistant answers "best injector near me," your reactivation message is competing with whatever that assistant recommends. AI search visibility is part of reactivation, not a separate project.
Measure reactivated patients and revenue per thousand contacts
Open rate tells you nothing about whether anyone sat in a chair.
Track two numbers:
- Reactivated patients. Unique patients who had not booked in their treatment specific window and who completed a visit within sixty days of the trigger.
- Revenue per thousand contacts. Total collected revenue from those visits, divided by the contacts messaged, times one thousand.
That second number is the one that ends arguments. It lets you compare a tox trigger against a laser series trigger against a cold paid campaign on the same scale, and it exposes a discount blast immediately: more bookings, lower revenue per thousand. Add average ticket for reactivated patients against new patients, and rebook rate at the next interval, and you have a reactivation program you can defend to anyone in the practice.
Reactivation is not a campaign you run once when the calendar looks thin. It is a standing system of treatment timed triggers, a message written like a clinician, and a human who closes. We build and run that system for aesthetic practices, alongside the paid campaigns and AI visibility work that fills the top of the calendar, so your team treats patients while the list quietly rebooks itself. If you want to know what your dormant file is actually worth, a free fifteen minute discovery call is the fastest way to find out.
Frequently asked questions
How long should I wait before calling a patient lapsed?
It depends on the treatment, not on the calendar. For neuromodulators, pooled Phase III data puts the median duration of effect at 120 days at maximum contraction, so a patient at month five is past peak and worth a note. For fillers and energy devices, build the window off the approved labeling for the specific product and the series interval in your clinical protocol.
Can I just send a discount to everyone who has gone quiet?
You can, and it usually costs more than it earns. On cash pay tickets the discount comes straight out of margin, and the patients most likely to respond are the ones who were going to rebook at full price anyway. Run it quarterly and you train your best patients to wait for the sale.
Should reactivation go out by text or email?
Email for the longer clinical explanation and anything educational, SMS for the short, time specific nudge to a patient with an obvious open window. A patient list is not a retail list, so consent, opt out handling and quiet hours need to be reviewed against federal and state rules before anything sends.
What should I measure instead of open rates?
Reactivated patients, meaning unique patients outside their treatment window who completed a visit within sixty days of the trigger, and revenue per thousand contacts messaged. Those two numbers let you compare a tox trigger against a laser trigger against a paid campaign on the same scale, and they expose a discount blast fast.
Who should handle the replies?
One named person with one inbox and one phone line, responding within the hour with a specific appointment time, plus a block of slots held back for reactivated patients. Marketing opens the door, the front desk closes it. Where evening and weekend coverage is thin, an AI receptionist can answer and book while the patient is still interested.
